As post-inflationary havoc ebbs and a slew of new funds flows, quarterly management fees surged at Blackstone, KKR, Apollo ...

The $45 bln miner’s shares are off 26% in a year, and it has ditched a potential US listing. With debt constraining returns, ...

The $210 bln Ozempic maker spends less than rivals on developing new drugs. That’s a problem as upstarts challenge its ...

After a worrisome quarter in both linear and online TV, boss Bob Iger unveiled deals with the NFL and WWE. Giving the US pro football league a 10% stake in ESPN helps fortify its rollout of a ...

The Alpine state is scrambling to reduce the US president’s 39% tariff on imports of its goods. Shrinking its trade surplus in products like pharmaceuticals is tricky. The least-bad option is to mimic ...

CEO Stephen Dacus offered few new details on how to revive growth after rival Couche Tarde's failed $46 bln takeover. Doubling down on previous pledges, like faster store openings and listing its ...

Tata Motors' latest cross-border acquisition comes with a peculiar Indian flavour. The automaker's heavy-vehicles unit will raise equity to pay off some of the 3.8 billion euro ($4.4 billion) loan for ...